Neurocrine Biosciences Inc number of employees

Neurocrine Biosciences Inc reported 1,800 employees at December 31, 2024 in its latest annual report, up 400 (28.6%) on the year before. That compares with 900 at December 31, 2021. Revenue per employee was $1.3m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2024	1,800	+400 (28.6%)	$1.3m	10-K, filed February 10, 2025
December 31, 2023	1,400	+200 (16.7%)	$1.3m	10-K, filed February 9, 2024
December 31, 2022	1,200	+300 (33.3%)	$1.2m	10-K, filed February 9, 2023
December 31, 2021	900	—	$1.3m	10-K, filed February 11, 2022

What the annual reports say

Human Capital Our Employees We have grown to a team of approximately 1,800 employees as of December 31, 2024, primarily employed in the U.S. 2024 annual report
We have grown to a team of more than 1,400 employees as of December 31, 2023, primarily employed in the U.S. 2023 annual report
We have grown to a team of more than 1,200 employees as of December 31, 2022, primarily employed in the United States. 2022 annual report
We have grown to a team of more than 900 employees as of December 31, 2021, all of whom were employed in the United States. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BMRN vs NBIX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Neurocrine Biosciences Inc's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neurocrine Biosciences Inc.